pitavastatin magnesium 2 MG Oral Tablet [Zypitamag]
pitavastatin magnesium
RxCUI: 2001264
What the CMS Formulary Data Shows for pitavastatin magnesium 2 MG Oral Tablet [Zypitamag]
Per the CMS 2026 Part D formulary file, pitavastatin magnesium 2 MG Oral Tablet [Zypitamag] (RxNorm concept RXCUI 2001264, generic name pitavastatin magnesium) appears on 21 distinct formulary files spanning 989 Medicare Part D plan offerings - 19.5% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.5.
Real-world access to pitavastatin magnesium 2 MG Oral Tablet [Zypitamag] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 95.2% require step therapy. 100% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 2,268 Part D beneficiaries filled pitavastatin magnesium 2 MG Oral Tablet [Zypitamag] in 2023, with total plan-and-beneficiary spending of $3,812,450 and an average per-beneficiary annual cost of $1,680.97. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry pitavastatin magnesium 2 MG Oral Tablet [Zypitamag] today.
Coverage Details
- Formularies covering
- 21
- Plans covering
- 989
- Coverage rate
- 19.5%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 95.2% of formularies
- Quantity limits
- 100% of formularies
2023 Medicare Spending
- Beneficiaries
- 2,268
- Total spending
- $3,812,450
- Avg per beneficiary
- $1,680.97
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering pitavastatin magnesium 2 MG Oral Tablet [Zypitamag]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is pitavastatin magnesium 2 MG Oral Tablet [Zypitamag] covered by Medicare Part D?
Yes, pitavastatin magnesium 2 MG Oral Tablet [Zypitamag] is covered by 989 Medicare Part D plans (19.5% of all Part D formularies).
What tier is pitavastatin magnesium 2 MG Oral Tablet [Zypitamag] on Medicare Part D plans?
pitavastatin magnesium 2 MG Oral Tablet [Zypitamag] averages Tier 3.5 across Part D plans, ranging from Tier 1 to Tier 4.
Does pitavastatin magnesium 2 MG Oral Tablet [Zypitamag] require prior authorization?
0% of Part D formularies require prior authorization for pitavastatin magnesium 2 MG Oral Tablet [Zypitamag]. Step therapy: 95.2%. Quantity limits: 100%.
How much does Medicare spend on pitavastatin magnesium 2 MG Oral Tablet [Zypitamag]?
In 2023, total Medicare Part D spending on pitavastatin magnesium 2 MG Oral Tablet [Zypitamag] was $3,812,450, covering 2,268 beneficiaries. The average spend per beneficiary was $1,680.97.
Read our methodology - how this data is sourced, computed, and verified.